LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, BTIG Research Analyst Says

LifeStance Health Group (NASDAQ:LFST) had its price target boosted by BTIG Research from $8.00 to $9.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s price objective points to a potential upside of 51.90% from the stock’s previous close.

LFST has been the topic of a number of other research reports. Wall Street Zen downgraded shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Weiss Ratings reiterated a “sell (e+)” rating on shares of LifeStance Health Group in a research note on Wednesday, October 8th. UBS Group raised their target price on LifeStance Health Group from $8.50 to $9.00 and gave the company a “buy” rating in a report on Friday, August 8th. Finally, Zacks Research cut LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $8.67.

LifeStance Health Group Stock Performance

NASDAQ:LFST traded down $0.33 during mid-day trading on Thursday, reaching $5.93. The stock had a trading volume of 1,347,145 shares, compared to its average volume of 1,978,617. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. The business has a 50 day simple moving average of $5.29 and a 200 day simple moving average of $5.27. LifeStance Health Group has a twelve month low of $3.74 and a twelve month high of $8.30. The firm has a market capitalization of $2.30 billion, a price-to-earnings ratio of -118.50 and a beta of 1.15.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, November 6th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $363.81 million for the quarter, compared to analyst estimates of $355.06 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.LifeStance Health Group’s revenue was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.02) EPS. LifeStance Health Group has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts expect that LifeStance Health Group will post -0.18 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder Summit Partners L. P sold 8,407,643 shares of the business’s stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the sale, the insider directly owned 33,524,715 shares in the company, valued at $169,970,305.05. The trade was a 20.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the firm’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the sale, the insider owned 14,324,197 shares of the company’s stock, valued at $72,623,678.79. The trade was a 20.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 20,407,643 shares of company stock valued at $103,466,750 over the last three months. Company insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

Hedge funds have recently modified their holdings of the stock. Teacher Retirement System of Texas bought a new position in shares of LifeStance Health Group during the 1st quarter valued at $130,000. DekaBank Deutsche Girozentrale bought a new stake in shares of LifeStance Health Group during the 1st quarter worth about $31,000. Cornerstone Investment Partners LLC acquired a new position in shares of LifeStance Health Group during the 1st quarter valued at about $156,000. Xponance Inc. bought a new position in shares of LifeStance Health Group in the 1st quarter valued at approximately $69,000. Finally, MQS Management LLC acquired a new stake in LifeStance Health Group in the 1st quarter worth approximately $119,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.